Dr. Reddy’s Laboratories has launched Vozet Tablets in Indian market. The drug is indicated for the treatment of allergic Rhinitis and chronic Urticaria. Vozet Tablets contain Levocetirizine 5 mg, and are available in a strip size of 10 tablets.
The anti-histamine market in India had sales of Rs 1,038 crore MAT for the most recent twelve months ended in March 2017, according to IMS data. The pharma major will further strengthen its anti-allergy portfolio with the addition of Vozet.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
